Impact of pretreatment serum cholinesterase level in unresectable advanced hepatocellular carcinoma patients treated with sorafenib

The value of serum cholinesterase (ChE) level as a predictive marker in sorafenib therapy for advanced hepatocellular carcinoma (HCC) has not yet been investigated. The present retrospective study therefore analyzed the impact of the serum ChE level in 93 patients with advanced HCC treated with sora...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: TAKEDA, HARUHIKO, NISHIKAWA, HIROKI, IGUCHI, ERIKO, OHARA, YOSHIAKI, SAKAMOTO, AZUSA, HATAMARU, KEIICHI, HENMI, SHINICHIRO, SAITO, SUMIO, NASU, AKIHIRO, KOMEKADO, HIDEYUKI, KITA, RYUICHI, KIMURA, TORU, OSAKI, YUKIO
Format: Artigo
Sprache:Inglês
Veröffentlicht: D.A. Spandidos 2013
Schlagworte:
Articles
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3956264/
https://ncbi.nlm.nih.gov/pubmed/24649154
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2012.48
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge